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ACKGROUND: The epidemic of obesity and type 
β diabetes presents a serious challenge to scientiic 
and biomedical communities worldwide. There 
has been an upsurge of interest in the adipocyte coincident 
with the onset of the obesity epidemic and the realization 
that adipose tissue plays a major role in the regulation of 
metabolic function.
CONTENT: Adipose tissue, best known for its role in 
fat storage, can also suppress weight gain and metabolic 
disease through the action of specialized, heat-producing 
adipocytes. Brown adipocytes are located in dedicated 
depots and express constitutively high levels of thermogenic 
genes, whereas inducible ‘brown-like’ adipocytes, also 
known as beige cells, develop in white fat in response to 
various activators. The activities of brown and beige fat 
cells reduce metabolic disease, including obesity, in mice 
and correlate with leanness in humans. Many genes and 
pathways that regulate brown and beige adipocyte biology 
have now been identiied, providing a variety of promising 
therapeutic targets for metabolic disease.
SUMMARY: The complexity of adipose tissue presents 
numerous challenges but also several opportunities for 
therapeutic intervention. There is persuasive evidence from 
animal models that enhancement of the function of brown 
adipocytes, beige adipocytes or both in humans could be very 
effective for treating type 2 diabetes and obesity. Moreover, 
there are now an extensive variety of factors and pathways 
that could potentially be targeted for therapeutic effects. 
In particular, the discoveries of circulating factors, such 
as irisin, ibroblast growth factor (FGF)β1 and natriuretic 
peptides, that enhance brown and beige fat function in 
mice have garnered tremendous interest. Certainly, the next 
L
ATAR BELAKANG: Epidemi obesitas dan 
diabetes tipe 2 menghadirkan tantangan yang 
serius bagi komunitas ilmiah dan biomedik di 
seluruh dunia. Terjadi peningkatan minat terhadap adiposit, 
bersamaan dengan onset epidemi obesitas dan kesadaran 
bahwa jaringan adiposa memainkan peran utama pada 
pengaturan fungsi metabolisme.
ISI: Jaringan adiposa, terkenal karena fungsinya sebagai 
penyimpanan adiposa, juga dapat menekan kenaikan berat 
badan dan penyakit metabolisme melalui adiposit khusus 
yang menghasilkan panas. Adiposit coklat terletak pada 
cadangan tertentu dan secara terus menerus mengekspresikan 
gen termogenik dalam kadar tinggi, sementara itu adiposit 
“brown-like”, yang dikenal sebagai sel beige, berkembang 
di dalam jaringan adiposa putih sebagai respon dari berbagai 
aktivator. Aktivitas sel adiposa coklat dan beige mengurangi 
penyakit metabolisme, termasuk obesitas, pada tikus dan 
berhubungan dengan kerampingan pada manusia. Beberapa 
gen dan jalur yang mengatur adiposit coklat dan beige telah 
teridentiikasi, dan menjadi target terapi yang  menjanjikan 
bagi penyakit metabolisme.
RINGKASAN: Kompleksitas jaringan adiposa 
menghadirkan berbagai tantangan dan juga kesempatan 
bagi terapi intervensi. Beberapa bukti persuasif pada hewan 
coba menunjukkan bahwa peningkatan fungsi adiposit 
coklat, beige, atau keduanya pada manusia sangat efektif 
untuk mengobati diabetes tipe 2 dan obesitas. Lebih lagi, 
ada berbagai faktor dan jalur ekstensif yang berpotensi 
sebagai target terapi. Secara khusus, penemuan faktor 
sirkulasi seperti irisin, ibroblast growth factor (FGF)β1, 
dan natriuretic peptide, yang mampu meningkatkan fungsi 
adiposa coklat dan beige, telah menarik banyak perhatian. 
Abstract Abstrak
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The epidemic of obesity and diabetes has greatly increased 
the interest in brown fat. Adipocytes can be broadly divided 
into white and brown fat cells. Whereas white fat cells are 
specialized to store chemical energy, brown adipocytes 
produce heat, counteracting hypothermia, obesity, and 
diabetes. Brown fat generates heat via the mitochondrial 
uncoupling protein 1 (UCP1), defending against 
hypothermia and obesity. Recent data suggest that there are 
two distinct types of brown fat: classical brown fat derived 
from a myf-5 cellular lineage and UCP1-positive cells that 
emerge in white fat from a non-myf-5 lineage.(1)
 Metabolically active brown adipose tissue (BAT) 
depots have been detected in adult humans by positron 
emission tomography/ computed tomography with the 
glucose analog F18-luorodeoxyglucose (FDG-PET/
CT). Human BAT is located mainly to the cervical, 
supraclavicular, and paravertebral areas and can be activated 
by cold.(2-7) The ‘‘brown-like’’ cells within white adipose 
depots are not derived from the myf-5 lineage and have been 
called ‘‘beige’’ or ‘‘brite’’ cells.(8-10) Interestingly, it has 
been reported that distinct genetic loci control the amounts 
of UCP1-positive cells in the white and classical brown fat 
depots (11-15), strongly suggesting that these two types of 
thermogenic cells are regulated differently. The therapeutic 
potential of both kinds of brown fat cells is clear (10,16), 
as genetic manipulations in mice that create more brown or 
beige fat have strong antiobesity and antidiabetic actions.
 It was recently proposed that supraclavicular fat of 
adult humans consists of beige rather than classical brown 
fat.(1,17) However, in order to exclude the possibility of the 
presence of classical brown fat in adult humans, the newly 
established markers must be compared with well-established 
markers in a larger sample set. This is important, as it is 
possible that the regulation and function of brown and beige 
adipose tissue differ, and the mode of recruiting the tissue 
for counteracting the development of obesity might depend 
on the nature of the tissue.(18) The hope is that molecules 
Introduction
that activate brown fat or induce the conversion of white fat 
to brown-like fat could help treat metabolic diseases such as 
obesity and diabetes.
Cellular bioenergetics are considered as a suitable target 
for antiobesity therapy. The capacity of energy production, 
heat release, and metabolic adaptations to either starvation, 
diet, cold, stress, and inlammation differ between subjects. 
Although the metabolic basis of these adaptations as well 
as the intraindividual and interindividual variances between 
them still remain to be characterized, modulation of AT to 
affect energy balance is challenging; its main regulators, 
that is, either sympathetic nervous system (SNS) activity, 
3,5,3’-tri-iodothyronine (T3), and/or leptin may provide a 
suitable basis for pharmacotherapies.(19)
 AT has been deined as the change in energy 
expenditure following acute and/or long-term overfeeding 
and underfeeding. In some studies, it has also been 
investigated by using catecholamines, caffeine, ephedrine 
and adrenergic blockers to induce changes in thermogenesis. 
As previously described (20), these stimuli were found to 
induce statistically signiicant changes in thermogenesis.
(21) AT may represent a defense mechanism that is set to 
protect energy stores from accelerated growth or depletion. 
The irst explanation that has been proposed to explain 
thermogenic variations in animals is related to the activity 
of BAT. As described by Rothwell and Stock (22), BAT 
activity has suficient impact on energy metabolism to 
explain individual variations in the proneness to obesity. 
Beyond the demonstration of validity of the greater-than-
predicted change in energy expenditure as a measure of 
adaptive thermogenesis (23), Rosenbaum et al. (24) have 
also contributed to identify some metabolic correlates of 
this variable. Indeed, a decrease in thermogenesis in weigh- 
reduced obese individuals was found to be associated with 
a decrease in plasma T3 and leptin, as well as sympathetic 
nervous system activity.(24)
decade will see massive efforts to use beige and brown fat 
to ameliorate human metabolic disease.
KEYWORDS: obesity, white adipose tissue, brown  adipose 
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Tentu saja, dekade berikut akan menunjukkan usaha 
besar-besaran penggunaan adiposa coklat dan beige untuk 
mengatasi penyakit metabolisme.
KATA KUNCI: obesitas, jaringan adiposa coklat, jaringan 
adiposa beige, organ adiposa, thermogenesis, pengeluaran 
energi
Adaptive Thermogenesis (AT) and 
Weight Loss
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 Although weight reduction is a dificult task, 
the maintenance of lost weight seems to require the 
deployment of even more efforts.(25) Indeed, the relapse 
of more than 80% of individuals to pre-weight-loss levels 
of body fatness after otherwise successful weight loss 
is likely due to the coordinated actions of metabolic, 
neuroendocrine, autonomic and behavioral changes that 
oppose the maintenance of a reduced body weight.(26) The 
occurrence of an apparent resistance to lose fat (plateau) 
is often interpreted as being the result of a lack of dietary 
and/or physical activity guidelines compliance. However, 
the adaptive reduction in thermogenesis can be suficiently 
pronounced in some cases to counteract further weight loss, 
even in the compliant patients.(20,27,28)
 As these thermogenic changes would seem to persist 
over time, they likely contribute to body weight regain 
following body weight loss. It thus seems important to 
further investigate adaptive thermogenesis in humans, be it 
for the development of relevant biomarkers or to improve 
diagnosis about individual determinants of the predisposition 
to obesity.(21) The existence of beige fat cells may represent 
an evolutionarily conserved cellular mechanism to provide 
lexibility in adaptive thermogenesis. It is likely that these 
beige adipocytes, rather than the classical brown fat cells, 
remain present in the adult state of larger mammals in which 
hypothermia is a less frequent threat than in rodents.(1) 
The therapeutic potential of activating brown-fat-mediated 
thermogenesis in human has yet to be fulilled. Trials of 
drugs that increase the b-adrenergic activation of BAT have 
not been successful in humans due to either lack of eficacy 
or to intolerable side effects resulting from activation of 
ȕ-adrenergic receptors in other tissues. Clearly, there is a 
need to develop more speciic means to activate brown fat 
in humans in more speciic ways.(β9,γ0)
The most important single idea in the ield of metabolic 
disease is the concept of energy balance. This means that, 
with the rare exception of mal-absorption of nutrients, an 
animal cannot gain or lose weight unless there is an imbalance 
between food intake and energy expenditure. When energy 
intake chronically exceeds energy expenditure, weight gain 
and obesity result. This excess weight is stored in adipose 
tissue, which consists of fat cells, or adipocytes, which have 
an incredible capacity for storing surplus energy in the form 
of lipid. This tissue is not just a passive storage depot, but also 
an endocrine organ, secreting molecules like leptin that can 
regulate appetite and whole-body metabolism. In addition 
to these well-described energy-storing fat cells, adipocytes 
also exist that are highly effective at transforming chemical 
energy into heat. Brown adipocytes, which get their name 
from their high number of iron-containing mitochondria, 
are specialized to dissipate energy in the form of heat, a 
process called non-shivering thermogenesis. Classical BAT 
is typically located in the interscapular region and is most 
easily detected in infants and small mammals. It is referred 
to as ‘‘classical’’ in distinction from the inducible or beige 
adipocyte, which has unique molecular and developmental 
characteristics.(31) BAT specializes in burning fat and is 
responsible for adaptive, nonshivering thermogenesis in 
mammals.(32)
 UCP1 is responsible for non-shivering thermogenesis 
in BAT. Upon activation by long-chain fatty acids (LCFAs), 
UCP1 increases the conductance of the inner mitochondrial 
membrane (IMM) to make BAT mitochondria generate heat 
rather than adenine triphosphate (ATP).(33) BAT burns fatty 
acids for heat production to defend the body against cold 
(32,34) and has recently been shown to be present in humans.
(3,4,35) Triglyceride-rich lipoproteins (TRLs) transport 
lipids in the bloodstream, where the fatty acid moieties 
are liberated by the action of lipoprotein lipase (LPL).(36) 
Increased BAT activity induced by short-term cold exposure 
controls TRL metabolism in mice. Cold exposure drastically 
accelerated plasma clearance of triglycerides as a result of 
increased uptake into BAT, a process crucially dependent 
on local LPL activity and trans-membrane receptor CD36. 
In pathophysiological settings, cold exposure corrected 
hyperlipidemia and improved deleterious effects of insulin 
resistance.(37)
 BAT is a highly energetic organ that not only utilizes 
its unique expression of UCP1 for uncoupling of respiration 
(i.e., cold or diet-induced thermogenesis), but is also a 
mitochondrially rich tissue that uses glucose and fatty acids 
as a fuel.(3,37-39) Adult humans have substantial depots of 
metabolically active BAT (3-5,7), suggesting that BAT may 
play a fundamental role in the maintenance of a leaner and 
more metabolically healthy phenotype.
 Cold exposure is the most powerful and physiological 
stimulus for BAT activation, both in small rodents and in 
humans.(7,40-44) It is known that the stimulatory effects 
of cold on BAT are mediated through the activation of 
the sympathetic nervous system, initiated by peripheral 
stimulation of transient receptor potential (TRP) channels 
in sensory neurons.(41,45) This pathway is also activated 
by some food ingredients, such as capsaicin and capsinoids, 
nonpungent capsaicin analogs.(46,47) Stimulation of TRP 
channels by capsinoids is effective for enhancement of BAT 
thermogenesis and upregulation of UCP1, a key molecule 
BAT
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of BAT thermogenesis, in mice.(47) It is therefore expected 
that the reactivation and/or recruitment of BAT may protect 
against the onset of obesity and related metabolic disorders 
in humans.(48)
The last few years have seen a paradigm shift with regard to 
the understanding of the origin of and relationship between 
adipose tissues. A series of investigations have demonstrated 
cell lineage.(10,5β) This is exempliied by the interscapular 
BAT depots and the perirenal BAT depot, a depot that 
contains a mixture of classical brown and white adipocytes.
(10,53) In addition, UCP1-positive, brown fat-like cells can 
emerge in most WAT depots upon prolonged cold exposure 
or  ȕ-adrenergic receptor activation.(54-56) These brown fat 
cells, which are not derived from a myf5-positive lineage, 
are designated beige or brown-in-white (beige) cells.(9,57)
 Compared with WAT, BAT is more extensively 
vascularized, and VEGF-α–dependent angiogenesis has 
been shown to be important for the thermogenic response to 
Beige Adipose Tissue
Figure 1. Shades of a cell.(58) (Adapted with permission from Nature Publishing Group).
that brown and white adipocytes are not sister cells, but 
rather, brown adipocytes are closely related to myocytes, 
and both originate from a common “adipomyocyte” 
precursor.(10,49,50) Furthermore, even among classical 
white adipocytes, it would seem that two types exist: the 
“genuine” white adipocytes and also “beige” adipocytes, a 
type of adipocyte that possesses the ability to express the 
UCP1, which until recently was believed to be a unique 
marker for brown adipocytes, but does not otherwise possess 
the full molecular characteristics of brown adipocytes. 
(9,10,12)
 Recent studies found that each adipose depot 
examined was characterized by a unique marker gene 
expression pattern. However, despite this, we conclude 
that it is possible to divide the depots into three main types, 
the classical BAT depots, the beige adipose tissue depots, 
and the (“genuine”) white adipose tissue (WAT) depots, 
and to associate particular gene expressions patterns with 
these depots.(51) It is now clear that there are two distinct 
types of brown adipose cells. One is the classical brown fat 
that arises from a myogenic factor 5 (myf5), muscle-like 
prolonged cold adaptation. (59) However, the role of BAT 
vascularity in maintaining systemic metabolic homeostasis 
under conditions of metabolic stress is unknown. Here, 
we show that obesity causes capillary rarefaction and 
hypoxia in BAT that is much more robust than in WAT. 
This condition leads to BAT “whitening” that is associated 
with diminished ȕ-adrenergic signaling, the accumulation 
of large lipid droplets, and mitochondrial dysfunction and 
loss. These changes in the BAT microenvironment impair 
thermogenic responses and contribute to dysfunctional 
glucose metabolism.(60) Browning of rodent WAT can be 
brought about by hormones and cytokines, such as Irisin 
(61) and ibroblast growth factor (FGF) β1 (6β), as well as by 
transcriptional modulation through PR domain containing 
(Prdm)16 (57), Forkhead box protein Cβ (FoxCβ) (6γ), 
receptor-interacting protein 140 (RIP140) (64), eukaryotic 
translation initiation factor 4E-binding protein 1 (4E-BP1) 
(65), transcriptional mediators/intermediary factor β (TIFβ) 
(66), retinoblastoma protein (pRb) and p107 (67). However, 
there is an unmet need for strategies that would translate 
these mechanisms into the clinic. (68)
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White adipose cells in mammals have the ability to store 
and release energy in the form of lipids. This function is 
essential as it allows intervals of fasting between meals and 
prolonged, week-long, fasting intervals.(69,70) The large 
spherical shape of white adipocytes its perfectly with their 
storage function because this geometric shape allows for 
maximum storage in minimal space. More than 90% of the 
volume of white adipocytes is occupied by a cytoplasmic 
unilocular lipid droplet consisting of triglycerides. White 
adipocytes are also able to secrete hormones (71) and 
several cytokines that inluence instinctual behaviour and 
metabolic pathways (70).
 Brown adipocytes are thermogenic cells that are 
highly regulated by the sympathetic nervous system to 
maintain body temperature when mammals are exposed to 
temperatures below thermoneutrality (approximately 28-
30°C).(72) To produce heat, brown adipocytes are activated 
by sympathetic nerves acting on beta3-adrenoceptors 
(beta3AR) to burn fatty acids in their unique spherical 
mitochondria, where the UCP1 protein in the inner 
membrane uncouples oxidative phosphorylation, resulting 
in energy dissipation in the form of heat.(32,73) Brown 
adipocytes store triglycerides in multiple small cytoplasmic 
lipid droplets so that they can rapidly burn large amounts of 
fatty acids.(74)
 Brown and white adipocytes appear to have different 
morphology and opposing functions, but detailed anatomic 
studies have shown that both types are contained together 
in several locations, forming a multi-depot adipose organ 
(75,76). Discrete depots are located in the subcutaneous 
space (subcutaneous depots) or in close vicinity to organs 
located in the trunk (visceral depots).(77) This inding has 
opened new perspectives in the physiological relationship 
between BAT and WAT, including the possibility of 
their reciprocal transformation (transdifferentiation) 
(56,66,78). Harnessing the mechanism of WAT to BAT 
transdifferentiation could be useful to develop treatments 
for obesity and type 2 diabetes, because the absence of BAT 
or its adrenergic receptors results in obesity (79,80) and 
transgenic mice overexpressing UCP1 in WAT are obesity 
resistant. (81,82)
Figure 2. Multidepot adipose organ of adult C5 & BL/6J female mice kept at 28°C (left) or 6°C (right) for 10 days.(82) (Adapted 
with permission from American Society for Biochemistry and Molecular Biology).
Adipose Organ Plasticity
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 Humans and mice harbour brown-like adipocytes in 
their predominantly white fat depots. (54,83) These beige 
(brown-in-white) adipocytes are also known as beige, 
inducible brown or brown-like adipocytes. (1,84,85) The 
abundance of this highly dynamic cell population is strain- 
and location-dependent (12,86) and it increases (beigening) 
in the cold whereas it decreases (whitening) in a warm 
environment (83,87). The inguinal (posterior subcutaneous) 
depot constitutes the best studied and, owing to its size, 
the most important fat tissue capable of recruiting beige 
adipocytes.(51) Each depot is associated with speciic 
nerve-vascular peduncles as are other organs in the body. 
Some researchers prefer to call these depots ‘mini-organs’ 
because of their autonomous anatomy and characteristics 
(88). Cinti et al. prefer the term ‘adipose organ’ to describe 
the general functional and plastic properties that are shared 
by most of its depots.(74)
 Intermediate forms of adipocytes between white 
and brown adipocytes are present in all depots of the 
adipose organ.(82,89) These intermediate adipocytes 
are multilocular but do not express the UCP1 protein, 
as indicated by immunohistochemistry. They also have 
mitochondria with intermediate features between those 
found in white and brown adipocytes. These cells could 
have a predominant lipid droplet and have been called 
paucilocular adipocytes.(56) Paucilocular adipocytes have a 
weak thermogenic capacity, in line with the idea that they are 
intermediate forms between white and brown adipocytes. 
These intermediate adipocytes are usually located in areas 
between WAT and BAT.(82)
 The reason why white and brown adipocytes, with 
different morphology and physiology, are contained 
together in the same organ is unclear, but it should be noted 
that they both share important features, such as the ability 
to store and release lipids and the expression of beta3AR. 
(90,91) Cinti et al. proposed a trans-differentiation theory: 
in speciic physiologic conditions (chronic cold exposure), 
white adipocytes transform into brown adipocytes to supply 
the thermogenic needs, and conversely, brown adipocytes 
transform into white adipocytes when the energy balance 
is positive and the adipose organ requires increased storage 
capacity.(92) This plasticity is not limited to these conditions 
because during pregnancy, lactation or post-lactation states 
in females, white adipocytes seem to have the ability to 
convert into milk-secreting epithelial cells 
 Thus, adult humans seem to have expandable 
metabolically active brown adipocytes. In addition, it has 
been proven that animals with abundant natural (82) or 
induced (81,93) BAT are resistant to obesity and that the 
administration of drugs that expand BAT is suficient to curb 
obesity and related disorders in rats. (55,94) Conversely, 
mice without functional brown adipocytes are prone to 
obesity and type 2 diabetes. (79,80) The white / brown 
plasticity of adipose tissue might have considerable medical 
implications, since the brown-like phenotype seems to 
correlate with a reduced propensity for developing obesity 
and diabetes in mice. (79-81,95,96)
The biomedical interest in brown and beige adipocytes has 
centered on the capacity of these cell types to counteract 
metabolic disease, including obesity and type 2 diabetes. 
Indeed, increased activities of brown and beige adipocytes 
have been linked to obesity resistance in many mouse 
models. (57,63,81) The key question now is whether 
reduced thermogenic activity in fat cells is a cause or a 
consequence of weight gain in humans. Regardless of its 
natural role, increasing the activity of brown fat, beige fat 
or both through drugs or other methods holds tremendous 
promise for the treatment of metabolic disease.(97)
 Most brown fat cells originate from precursor cells in 
the embryonic mesoderm that also give rise to skeletal muscle 
cells and a subpopulation of white adipocytes. (10,52,98) 
These precursors transiently express Myf5 and paired 
box (Pax),(82) two genes that were previously thought to 
selectively mark skeletal myogenic cells in the mesoderm.
(10,52) Consistent with a developmental relationship 
between brown fat and muscle, brown fat precursor cells 
express a muscle-like gene signature, (50) and brown fat 
and muscle have related mitochondrial proteomes. (99) The 
embryonic origin and cell hierarchy of beige adipocytes 
is less clear. Beige and brown adipocytes probably come 
from distinct cell lineages, given that beige cells, at least 
in the subcutaneous depot, do not have a history of Myf5 
expression.(10,98)
 Over a decade ago, Himms-Hagen et al. (77) found 
that most beige adipocytes arise from pre-existing (non-
dividing) cells that they presumed were mature adipocytes. 
Since then, Cinti and others have provided substantial 
evidence in support of the idea that large unilocular white 
adipocytes transform into beige adipocytes in response to 
cold or ȕγ-adrenergic agonists. (8β) Wang et al. indicates 
that most, if not all, beige adipocytes (at least in this 
subcutaneous depot) arise from a precursor population 
rather than from pre-existing adipocytes.
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 The thermogenic proile of beige adipocytes is 
reversible. Beige adipocytes acquired in WAT during cold 
exposure lose UCP1 expression and are retained after 
mice are moved back to warmer conditions. When these 
mice are re-exposed to cold, the same cells again induce 
UCP1 expression.(101) Interestingly, the cells marked by 
previous UCP1 expression were not the only source of beige 
adipocytes during the second round of cold exposure. This 
suggests that beige adipocytes are retained and may function 
similarly to white fat cells for a certain period of time in 
animals that were previously cold. These beige adipocytes 
are presumably depleted through the normal mechanisms 
that control tissue turnover.(97)
 Prdm16 is a large zinc inger–containing transcriptional 
factor that is highly expressed in mouse BAT relative to 
visceral WAT.(102) Prdm16 expression is also substantially 
enriched in human BAT relative to adjacent subcutaneous 
WAT. (5,103) Several factors have been shown to regulate 
brown and beige adipocyte differentiation by modulating 
Prdm16 expression or activity. Notable among these factors 
is bone morphogenetic protein 7 (BMP7), a signal that is 
essential for brown fat development, which increases the 
amounts of Prdm16 mRNA in brown and white fat precursor 
cells.(84,104,105) Additionally, thiazolidinediones (TZDs), 
which agonize peroxisome proliferator-activated receptors 
(PPAR)-Ȗ, induce thermogenic gene expression in fat cells 
through effects on Prdm16.(48,106)
 Mice with increased activity of brown fat, beige fat 
or both resist weight gain but also display improvements in 
systemic metabolism, including improved glucose tolerance 
and increased insulin sensitivity.(61,63,107,108) Along 
these lines, activated brown fat takes up and metabolizes 
large quantities of lipid from the bloodstream, (37) which has 
beneicial effects on metabolism. The increased proportion 
of beige to white adipocytes in WAT modulates systemic 
insulin action through nonthermogenic mechanisms, perhaps 
by altering the secretome of adipose tissue. Additionally, 
thermogenic fat cells, not yet classiied as brown or beige, 
that surround blood vessels (perivascular adipose) have 
been suggested to protect against the development of 
atherosclerosis.(109) Thus, the potential therapeutic uses 
of brown and beige fat go beyond obesity and should be 
Figure 3. Transcriptional regulation of brown and beige adipocyte development.(97) (Adapted with permission from Nature Publishing 
Group).
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considered for various metabolic disturbances, including 
type 2 diabetes, insulin resistance, atherosclerosis and lipid 
disorders.(97)
Increasing energy expenditure is an attractive approach 
to ighting the worldwide epidemic in obesity and type β 
diabetes. Exercise is an important component of good 
health and represents the irst line of therapy for humans 
with a variety of metabolic disorders: obesity, diabetes, 
and nonalcoholic hepatic steatosis. Recent data has shown 
that exercise, besides using calories to do physical work, 
also causes an increase in energy expenditure through 
augmentation in brown fat and the browning of white fat.
(61,110) Indeed, these effects on brown fat could represent 
part of the longer-lasting beneits of exercise.
 That brown fat, in all of its dimensions, can improve 
type 2 diabetes and metabolic health seems to be settled 
science, at least in experimental animals.  These cells 
express UCP1 and have a high mitochondrial content, 
thereby dissipating chemical energy in the form of heat. In 
fact, the improvements seen in glucose tolerance observed 
with “browning” of white fat and the formation of “beige” 
or “brite” cells might be greater than expected solely from 
their effects on body weight and adiposity.(111) Several 
polypeptides, including FGFβ1, BMP7/8b, brain natriuretic 
peptide (BNP)/atrial natriuretic peptide (ANP), and orexin, 
all have interesting browning effects. (62,104,108,112,113) 
 Irisin was of interest because it is induced during 
exercise in rodents and is at least partially responsible for 
the browning response observed in white fat during chronic 
exercise.(61) The parent polypeptide, ibronectin type III 
domain containing 5 (FNDC5), is synthesized as a type 1 
membrane protein and is then cleaved and shed into the 
circulation as a highly glycosylated polypeptide of roughly 
12 kDa. Irisin appears to act preferentially on the browning 
of white fat deposits when elevated in the blood of obese 
mice via viral vectors. This correlates with improvements in 
glucose tolerance in obese mice. Regarding human irisin, it 
is clear that FNDC5 mRNA is increased in skeletal muscle 
in some exercise paradigms but not others. (61,114,115) 
Interestingly, two articles report that human patients with 
diabetes are deicient in irisin compared with normal 
counterparts.(116,117)
 FGFβ1 is a recently discovered metabolic regulator. 
Exogenous FGFβ1 produces beneicial metabolic effects 
in animal models; however, the translation of these 
observations to humans has not been tested. Gaich et al. 
studied the effects of LYβ405γ19, a variant of FGFβ1, in 
a randomized, placebo-controlled, double-blind proof-of-
concept trial in patients with obesity and type 2 diabetes. 
The results indicate that FGFβ1 is bioactive in humans and 
suggest that FGFβ1-based therapies may be effective for the 
treatment of selected metabolic disorders.(118)
 Atrial natriuretic peptide and brain-type natriuretic 
peptide are released by the heart in response to heart failure 
or pressure overload. These factors reduce blood volume, 
blood pressure and cardiac output by dilating blood vessels 
and promoting salt and luid excretion from the kidneys. 
Atrial natriuretic peptide is also known to promote lipolysis 
in adipocytes. Notably, high circulating concentrations of 
natriuretic peptides have also been associated with weight 
loss in humans.(119,120) The effects of natriuretic peptides 
on brown and beige adipogenesis suggest that the control of 
adaptive thermogenesis is more complex than is currently 
appreciated. Cardiomyocytes, a cell type that is thought to 
have little crosstalk with adipocytes, can markedly alter 
the gene expression and function of adipose through the 
secretion of potent cardiometabolic hormones. Importantly, 
cold increases the concentrations of natriuretic peptides, 
suggesting that this browning system may have evolved, 
perhaps in epicardial fat, to safeguard cardiac function in 
animals during cold exposure.(97)
 Cyclooxygenase-2 (COX2, the rate-limiting enzyme 
in prostaglandin synthesis) and WAT-derived prostaglandins 
(PGEβ and PGIβ) appear to be crucially involved 
downstream of ȕ-adrenergic stimulation in the induction 
of UCP1 expression in adipocytes in inguinal WAT, but 
not in classic interscapular brown adipocytes.(122,123) 
Overexpression of COX2 in WAT results in WAT browning, 
increased systemic energy expenditure, and protection 
against dietary obesity.(122) Importantly, evidence has been 
obtained that COX-dependent induction of UCP1 in WAT 
is important for diet-induced thermogenesis and energy 
balance in obesity-resistant mice.(123)
 Capsaicin (8-methyl-N-vanillyl-6-nonenamide, a 
major ingredient in hot pepper widely used as a spice in 
food) and nonpungent capsaicin analogs (capsinoids) have 
an anti-obesity action in rodents linked to SNS activation. 
Reported effects of these compounds include activation of 
BAT thermogenesis and whole body energy expenditure in 
both rodents and humans (124), inhibition of adipogenesis 
(125) and stimulation of lipid catabolism (126) in white 
adipocyte cell models, and induction of browning of WAT in 
high-fat diet-fed rats supplemented with capsaicin (127). The 
bioactivity of capsaicin has been related to enhancement of 
catecholamine secretion from the adrenal medulla through 
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activation of the SNS (128), and to binding to and activation 
of speciic TRP channels within the gastrointestinal tract 
(47) and visceral adipose tissue (125).
 Fucoxanthin is an allenic carotenoid present in the 
chloroplasts of edible brown algae. It is themost abundant 
of all carotenoids, accounting for more than 10% of the 
estimated total natural production of carotenoids.(129) 
Fucoxanthin metabolites accumulate in abdominal WAT.
(1γ0) Fucoxanthin or fucoxanthin-rich seaweed extract, 
alone or as part of mixtures with other selected agents, has 
been shown to counteract the development of dietary obesity 
and reduce abdominal WAT in obese animals through 
mechanisms that include the stimulation of WAT browning, 
with induction of UCP1 mRNA and protein expression and 
lipid catabolism-related genes in abdominal WAT.(131-135) 
Notably, fucoxanthin intake promotes WAT browning at 
doses at which it does not affect UCP1 expression in BAT, 
suggesting a WAT selective effect.(131)
 Stimulatory effects of olive oil on the expression of 
UCPs have been described. Its previously demonstrated 
capacity to enhance the cyclic adenosine monophosphate 
(cAMP)/Protein Kinase A pathway (136) since 
phosphorylation of cAMP response element-binding protein 
(CREB) was drastically increased together with UCP1 
expression in WAT of treated rats (137).
 Conjugated linoleic acid is a group of dietary fatty 
acids that have received considerable attention due to their 
ability to signiicantly reduce adipose mass in a variety 
of species. The mechanisms by which CLA (speciically 
the trans-10, cis-12 isomer) depletes adipose mass may 
include a combination of increased apoptosis, decreased 
preadipocyte differentiation and lipogenesis, and increased 
fatty acid oxidation and energy expenditure in white 
adipocytes.(138) Intake of long-chain n-3 polyunsaturated 
fatty acids (PUFA) eicosapentaenoic acid (EPA) (β0:5 n-γ) 
and docosahexaenoic acid (DHA) (22:6 n-3), which are 
abundant in marine ish oil, reduces obesity and visceral fat 
mass in rodents and, although evidence is limited, possibly 
also in humans.(1γ9) The anti-adiposity effect of n-γ PUFA 
does not result from a reduction in food intake, but rather 
Figure 4. Pharmacological agents, endogenous signals and dietary chemicals/conditions that have been related to the browning of 
WAT.(121) (Adapted with permission from Elsevier)
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